Your browser doesn't support javascript.
loading
Inhibition of SRPK1, a key splicing regulator, exhibits antitumor and chemotherapeutic-sensitizing effects on extranodal NK/T-cell lymphoma cells.
He, Cuiying; Liu, Beichen; Wang, Huan-You; Wu, Lili; Zhao, Guimin; Huang, Chen; Liu, Yueping; Shan, Baoen; Liu, Lihong.
Afiliação
  • He C; Department of Hematology, The Fourth Hospital of Hebei Medical University, NO.169, TianShan Street, Shijiazhuang, 050035, Hebei, China.
  • Liu B; Hebei Provincial Key Laboratory of Tumor Microenvironment and Drug Resistance, Shijiazhuang, China.
  • Wang HY; Hebei Medical University, Shijiazhuang, China.
  • Wu L; Department of Hematology, The Fourth Hospital of Hebei Medical University, NO.169, TianShan Street, Shijiazhuang, 050035, Hebei, China.
  • Zhao G; Hebei Provincial Key Laboratory of Tumor Microenvironment and Drug Resistance, Shijiazhuang, China.
  • Huang C; Department of Pathology, University of California San Diego, San Diego, CA, USA.
  • Liu Y; Department of Hematology, The Fourth Hospital of Hebei Medical University, NO.169, TianShan Street, Shijiazhuang, 050035, Hebei, China.
  • Shan B; Department of Hematology, The Fourth Hospital of Hebei Medical University, NO.169, TianShan Street, Shijiazhuang, 050035, Hebei, China.
  • Liu L; Department of Hematology, The Fourth Hospital of Hebei Medical University, NO.169, TianShan Street, Shijiazhuang, 050035, Hebei, China.
BMC Cancer ; 22(1): 1100, 2022 Oct 27.
Article em En | MEDLINE | ID: mdl-36303126

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Extranodal de Células T-NK Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Extranodal de Células T-NK Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article